Entering text into the input field will update the search result below

Diffusion raised to Buy at H.C. Wainwright after Q2 update on lead asset

Aug. 16, 2022 12:58 PM ETCervoMed Inc. (CRVO) StockBy: Dulan Lokuwithana, SA News Editor

Wall street sign in New York with New York Stock Exchange background

naphtalina/iStock via Getty Images

H.C. Wainwright upgraded clinical-stage biotech Diffusion Pharma (NASDAQ:DFFN) to Buy from Neutral on Tuesday, citing the company's Q2 2022 update on its lead candidate Trans Sodium Crocetinate (TSC) in glioblastoma multiforme (GBM).

Following positive data for

Recommended For You

More Trending News

About CRVO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CRVO--
CervoMed Inc.